Holen Sie sich die Stockscreener-App
8.27
0.73%
0.06
Handel nachbörslich:
8.27
Theravance Biopharma Inc Aktie (TBPH) Neueste Nachrichten
Theravance Biopharma (TBPH) Scheduled to Post Earnings on Tuesday - MarketBeat
Vanguard Group Inc's Strategic Acquisition in Theravance Biophar - GuruFocus.com
(TBPH) Proactive Strategies - Stock Traders Daily
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Sold by SG Americas Securities LLC - MarketBeat
When (TBPH) Moves Investors should Listen - Stock Traders Daily
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
Q3 EPS Estimate for Theravance Biopharma Boosted by Analyst - MarketBeat
Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75 - Defense World
What is Zacks Research's Estimate for TBPH Q4 Earnings? - MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Average Rating of "Hold" by Analysts - MarketBeat
The Manufacturers Life Insurance Company Decreases Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Theravance study shows YUPELRI improves COPD lung function By Investing.com - Investing.com Australia
Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat
Theravance study shows YUPELRI improves COPD lung function - Investing.com
Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease - StockTitan
Where are the Opportunities in (TBPH) - Stock Traders Daily
Dimensional Fund Advisors LP Has $2.80 Million Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
Theravance Biopharma (STU:0TB) Price-to-Operating-Cash-Flow : (As of Oct. 10, 2024) - GuruFocus.com
Squarepoint Ops LLC Takes $986,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
Bank of Montreal Can Raises Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH) Stock Holdings Lifted by Marshall Wace LLP - MarketBeat
(TBPH) Pivots Trading Plans and Risk Controls - Stock Traders Daily
XTX Topco Ltd Purchases New Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y - MSN
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Rhumbline Advisers Sells 15,095 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
An Analysis of Theravance Biopharma Inc (TBPH)’s Potential Price Growth - Knox Daily
Theravance Biopharma settles patent litigation with Qilu Pharmaceutical - Investing.com
Baupost Group LLC MA Decreases Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Given “Buy” Rating at HC Wainwright - Defense World
H.C. Wainwright maintains Buy rating on Theravance Biopharma shares By Investing.com - Investing.com Canada
Theravance Biopharma (NASDAQ:TBPH) Earns Buy Rating from HC Wainwright - MarketBeat
Unveiling 4 Analyst Insights On Theravance Biopharma - Benzinga
How To Trade (TBPH) - Stock Traders Daily
Leerink Partners gives a Market perform recommendation for Theravance Biopharma Inc (TBPH) - Knox Daily
Seth Klarman's Complete Exit from Theravance Biopharma Inc - Yahoo Finance
Theravance Biopharma Outlines Growth Strategy at Investment Conference - TipRanks
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation - Yahoo Finance
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Theravance Biopharma Inc (TBPH) receives a Market perform rating from Leerink Partners - Knox Daily
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of “Hold” by Analysts - Defense World
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives $13.75 Consensus Target Price from Analysts - MarketBeat
Q3 2024 EPS Estimates for Theravance Biopharma, Inc. (NASDAQ:TBPH) Reduced by Analyst - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 50-Day Moving Average of $8.90 - MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH) to Post Q4 2025 Earnings of $0.41 Per Share, Zacks Research Forecasts - Defense World
Zacks Research Brokers Increase Earnings Estimates for Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizentribune
Theravance Biopharma (NASDAQ:TBPH) Stock Crosses Below Fifty Day Moving Average of $8.90 - Defense World
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024 - MSN
Leerink Partners Downgrades Theravance Biopharma Inc (TBPH) to a Market perform from an Outperform - Knox Daily
TBPH (Theravance Biopharma) 14-Day RSI : 42.38 (As of Aug. 20, 2024) - GuruFocus.com
TBPH (Theravance Biopharma) Short-Term Debt & Capital Lease Obligation : $4.22 Mil (As of Jun. 2024) - GuruFocus.com
TBPH (Theravance Biopharma) 3-Year Revenue Growth Rate : -3.40% (As of Jun. 2024) - GuruFocus.com
TBPH (Theravance Biopharma) LT-Debt-to-Total-Asset : 0.12 (As of Jun. 2024) - GuruFocus.com
TBPH (Theravance Biopharma) Free Cash Flow : $-9.60 Mil (TTM As of Jun. 2024) - GuruFocus.com
SG Americas Securities LLC Sells 47,178 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):